STOCKWATCH
·
Pharmaceuticals
Management Change27 Mar 2026, 12:05 pm

Biocon Ltd Announces Leadership Changes: New CEO, CFO, and Key Managerial Personnel

AI Summary

Biocon Ltd, a leading biopharmaceutical company, has announced significant leadership changes. The Board accepted the resignation of Mr. Siddharth Mittal as CEO and Managing Director and Mr. Mukesh Kamath as Interim Chief Financial Officer. Mr. Shreehas Pradeep Tambe has been appointed as the new CEO and Managing Director, while Mr. Kedar Narayan Upadhye will take over as the Chief Financial Officer. The company has also designated new Key Managerial Personnel and Senior Management Personnel, and announced the cessation of several Senior Management Personnel. These changes will be effective from April 1, 2026.

Key Highlights

  • Mr. Siddharth Mittal resigns as CEO and Managing Director of Biocon Ltd.
  • Mr. Shreehas Pradeep Tambe appointed as the new CEO and Managing Director.
  • Mr. Kedar Narayan Upadhye takes over as the new Chief Financial Officer.
  • New Key Managerial and Senior Management Personnel designated.
  • Several Senior Management Personnel cease to hold their positions.
BIOCON
Pharmaceuticals
BIOCON LTD.

Price Impact